Last reviewed · How we verify

NCT06084247

The Efficacy of the KARL STORZ Curved Fetoscope and Straight Fetoscope for Laser Photocoagulation of Placental Anastomoses

Not yet recruiting NA Last updated 14 August 2025
What this trial tests

NA trial testing Curved KARL STORZ fetoscope in Twin to Twin Transfusion Syndrome in 160 participants. Not yet recruiting.

Timeline
1 September 2025
Primary endpoint
1 November 2026
1 December 2027

Quick facts

Lead sponsorJimmy Espinoza
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment160
Start date1 September 2025
Primary completion1 November 2026
Estimated completion1 December 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Jimmy Espinoza

Who can join

Adults 18 to 45, female only, with Twin to Twin Transfusion Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the efficacy of KARL STORZ curved fetoscope (11508AAK) and its straight version (11506AAK) for laser photocoagulation of placental anastomoses in patients with an anterior placenta and Twin to Twin Transfusion Syndrome (TTTS).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Twin to Twin Transfusion Syndrome

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06084247.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing